Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Nanologica AB ( (SE:NICA) ) has shared an announcement.
Nanologica AB has called its shareholders to the annual general meeting on 21 May 2026 in Stockholm, setting the formal agenda for approving its 2025 financial statements, electing board members and auditors, and deciding on remuneration and capital structure matters. The board proposes that the company’s loss of SEK 50.2 million be carried forward, while board and committee fees remain unchanged at a total of SEK 1.24 million, underscoring a cautious stance on governance costs as the company seeks shareholder approval for issues such as an authorization to issue new shares and a reduction of share capital, measures that may influence future financing flexibility and balance-sheet management.
More about Nanologica AB
Nanologica AB is a Swedish public company based in Södertälje, operating in the life science and advanced materials sector. The company focuses on technologies built around silica-based materials, with applications that typically span chromatography, drug delivery and related pharmaceutical and analytical solutions aimed at global healthcare and industrial customers.
Average Trading Volume: 175,338
Technical Sentiment Signal: Sell
Current Market Cap: SEK128.2M
For an in-depth examination of NICA stock, go to TipRanks’ Overview page.